Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer screening in people living with HIV. | Cancer Med | 2023 | 37877338 | PubTator, text mining | PubMed |
| Genome-wide association study of thyroid-stimulating hormone highlights new genes, pathways and associations with thyroid disease. | Nat Commun | 2023 | 37872160 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential. | Cancers (Basel) | 2023 | 37835573 | PubTator, text mining | PubMed |
| The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer. | Cancers (Basel) | 2023 | 37835396 | PubTator, text mining | PubMed |
| Role of DNA Methylation Profiles as Potential Biomarkers and Novel Therapeutic Targets in Head and Neck Cancer. | Cancers (Basel) | 2023 | 37835379 | PubTator, text mining | PubMed |
| PD-1/PD-L1 Inhibitors Response in Triple-Negative Breast Cancer: Can Long Noncoding RNAs Be Associated? | Cancers (Basel) | 2023 | 37835376 | PubTator, text mining | PubMed |
| Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach. | Virus Res | 2023 | 37832654 | PubTator, text mining | PubMed |
| Cell Surface Engineering Tools for Programming Living Assemblies. | Adv Sci (Weinh) | 2023 | 37823678 | PubTator, text mining | PubMed |
| CADM1 impairs the effect of miR-1246 on promoting cell cycle progression in chemo-resistant leukemia cells. | BMC Cancer | 2023 | 37814227 | PubTator, text mining | PubMed |
| Molecular triaging options for women testing HPV positive with self-collected samples. | Front Oncol | 2023 | 37810963 | PubTator, text mining | PubMed |
| Molecular epidemiological analyses of Clostridioides difficile isolates in a university hospital in Japan. | Heliyon | 2023 | 37800060 | PubTator, text mining | PubMed |
Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3+ dendritic cells with CD4+ regulatory T cells and CD8+ exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implications. | Cancer Commun (Lond) | 2023 | 37794698 | PubTator, text mining | PubMed |
| Protein Arginine Methyltransferases Refine the Classification of Clear Cell Renal Cell Carcinoma with Distinct Prognosis and Tumor Microenvironment Characteristics. | Int J Biol Sci | 2023 | 37781030 | PubTator, text mining | PubMed |
| Current perspective on biological properties of plasmacytoid dendritic cells and dysfunction in gut. | Immun Inflamm Dis | 2023 | 37773693 | PubTator, text mining | PubMed |
| Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro. | Front Cell Dev Biol | 2023 | 37771376 | PubTator, text mining | PubMed |
| Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer. | Biologics | 2023 | 37767463 | PubTator, text mining | PubMed |
| Efficiency of CIN2+ Detection by Thyrotropin-Releasing Hormone (TRH) Site-Specific Methylation. | Viruses | 2023 | 37766209 | PubTator, text mining | PubMed |
| Small Organic Compounds Mimicking the Effector Domain of Myristoylated Alanine-Rich C-Kinase Substrate Stimulate Female-Specific Neurite Outgrowth. | Int J Mol Sci | 2023 | 37762575 | PubTator, text mining | PubMed |
| Use of a Local Anaesthetic/Antiseptic Formulation for the Treatment of Lambs Experimentally Infected with Orf Virus. | Animals (Basel) | 2023 | 37760362 | PubTator, text mining | PubMed |
| Structural and functional characterization of USP47 reveals a hot spot for inhibitor design. | Commun Biol | 2023 | 37740002 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=12